MX2009009884A - Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico. - Google Patents

Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.

Info

Publication number
MX2009009884A
MX2009009884A MX2009009884A MX2009009884A MX2009009884A MX 2009009884 A MX2009009884 A MX 2009009884A MX 2009009884 A MX2009009884 A MX 2009009884A MX 2009009884 A MX2009009884 A MX 2009009884A MX 2009009884 A MX2009009884 A MX 2009009884A
Authority
MX
Mexico
Prior art keywords
composition
antimycotic
glucocorticoid
antimicrobial
combination
Prior art date
Application number
MX2009009884A
Other languages
English (en)
Inventor
Salgado López Raúl García
Hernández Gustavo Barranco
Original Assignee
Laboratorios Senosiain S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Senosiain S A De C V filed Critical Laboratorios Senosiain S A De C V
Priority to MX2009009884A priority Critical patent/MX2009009884A/es
Priority to CA2774356A priority patent/CA2774356C/en
Priority to PE2012000327A priority patent/PE20121351A1/es
Priority to BR112012005895A priority patent/BR112012005895B8/pt
Priority to ARP100103350A priority patent/AR078370A1/es
Priority to ES10816763T priority patent/ES2716505T3/es
Priority to PCT/IB2010/002301 priority patent/WO2011033361A2/es
Priority to EP10816763.6A priority patent/EP2478908B1/en
Priority to US13/496,164 priority patent/US8895538B2/en
Publication of MX2009009884A publication Critical patent/MX2009009884A/es
Priority to ECSP12011727 priority patent/ECSP12011727A/es
Priority to CR20120114A priority patent/CR20120114A/es
Priority to HN2012000527A priority patent/HN2012000527A/es
Priority to DO2012000065A priority patent/DOP2012000065A/es
Priority to CO12044629A priority patent/CO6511242A2/es
Priority to GT201200074A priority patent/GT201200074A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica tópica que comprende la combinación de un antimicrobiano, un glucocorticoide, un antimicótico y vehículos o excipientes farmacéuticamente aceptables; el proceso de fabricación de la composición y el uso de dicha composición para tratamiento de padecimientos localizados de dermatosis.
MX2009009884A 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico. MX2009009884A (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
MX2009009884A MX2009009884A (es) 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.
EP10816763.6A EP2478908B1 (en) 2009-09-15 2010-09-14 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
US13/496,164 US8895538B2 (en) 2009-09-15 2010-09-14 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
BR112012005895A BR112012005895B8 (pt) 2009-09-15 2010-09-14 combinação e composição contendo um agente antimicrobiano,um glucocorticóide e um agente antifúngico
ARP100103350A AR078370A1 (es) 2009-09-15 2010-09-14 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico
ES10816763T ES2716505T3 (es) 2009-09-15 2010-09-14 Combinación y composición que contiene un antimicrobiano, un glucocorticoide y un antimicótico
PCT/IB2010/002301 WO2011033361A2 (es) 2009-09-15 2010-09-14 Combinación y composición que contiene un antimicrobiano, un glucocorticoide y un antimicótico
CA2774356A CA2774356C (en) 2009-09-15 2010-09-14 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
PE2012000327A PE20121351A1 (es) 2009-09-15 2010-09-14 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico
ECSP12011727 ECSP12011727A (es) 2009-09-15 2012-03-12 Combinación y composición que contiene un antimicrobiano, un glucocorticoide y un antimicotico
CR20120114A CR20120114A (es) 2009-09-15 2012-03-12 Combinación y composición que comprende un antimicrobiano, un glucocorticoide y un antimicótico
HN2012000527A HN2012000527A (es) 2009-09-15 2012-03-13 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico
DO2012000065A DOP2012000065A (es) 2009-09-15 2012-03-13 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico
CO12044629A CO6511242A2 (es) 2009-09-15 2012-03-14 Combinación y composición que contiene un antimicrobiano, un glucocorticoide y un antimicótico
GT201200074A GT201200074A (es) 2009-09-15 2012-03-15 Combinación y composición que contiene un antimicrobiano, un glucocorticoide y un antimicótico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009009884A MX2009009884A (es) 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.

Publications (1)

Publication Number Publication Date
MX2009009884A true MX2009009884A (es) 2011-03-16

Family

ID=43759111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009884A MX2009009884A (es) 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.

Country Status (15)

Country Link
US (1) US8895538B2 (es)
EP (1) EP2478908B1 (es)
AR (1) AR078370A1 (es)
BR (1) BR112012005895B8 (es)
CA (1) CA2774356C (es)
CO (1) CO6511242A2 (es)
CR (1) CR20120114A (es)
DO (1) DOP2012000065A (es)
EC (1) ECSP12011727A (es)
ES (1) ES2716505T3 (es)
GT (1) GT201200074A (es)
HN (1) HN2012000527A (es)
MX (1) MX2009009884A (es)
PE (1) PE20121351A1 (es)
WO (1) WO2011033361A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687206A (zh) * 2014-11-27 2016-06-22 四川海思科制药有限公司 一种夫西地酸戊酸倍他米松乳膏药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298604B1 (en) 1980-10-06 1998-12-22 Schering Corp Clotrimazole-betamethasone dipropionate combination
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
RU2470645C2 (ru) * 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
WO2010106465A1 (en) 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
US20120035144A1 (en) 2009-04-20 2012-02-09 Apex Laboratories Private Limited Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
WO2010122475A1 (en) 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it

Also Published As

Publication number Publication date
BR112012005895B8 (pt) 2021-05-25
EP2478908A4 (en) 2013-04-03
CR20120114A (es) 2012-06-08
ECSP12011727A (es) 2012-04-30
GT201200074A (es) 2014-03-05
DOP2012000065A (es) 2012-05-31
HN2012000527A (es) 2014-09-22
US8895538B2 (en) 2014-11-25
EP2478908A2 (en) 2012-07-25
AR078370A1 (es) 2011-11-02
EP2478908B1 (en) 2018-12-26
WO2011033361A3 (es) 2011-07-21
US20120178727A1 (en) 2012-07-12
CO6511242A2 (es) 2012-08-31
CA2774356C (en) 2017-05-30
PE20121351A1 (es) 2012-10-27
BR112012005895B1 (pt) 2020-11-24
ES2716505T3 (es) 2019-06-12
WO2011033361A2 (es) 2011-03-24
CA2774356A1 (en) 2011-03-24
BR112012005895A2 (pt) 2017-06-06

Similar Documents

Publication Publication Date Title
IN2012DN02805A (es)
WO2014107740A3 (en) Methods for reducing cellular proliferation and treating certain diseases
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
MX2009013971A (es) Derivado de sulfonamida de acido malonico novedoso y su uso farmaceutico.
EP2513343A4 (en) METHODS AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION
MA32934B1 (fr) Combinaisons inhibitrices hsp90
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
MX2015016425A (es) Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
MX2009010407A (es) Derivados fluorados de deferiprona.
MY149028A (en) Nalmefene hydrochloride dihydrate
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
WO2007115286A3 (en) Combinations of therapeutic agents for treating cancer
MA32933B1 (fr) Combinaison d'inhibiteurs de hspo90 et d'herceptine
MX2009009884A (es) Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.
MX2012004282A (es) Composiciones farmaceuticas.
GB201312583D0 (en) Combination and composition for treating obesity
MX2011006758A (es) Composicion farmaceutica para uso en inflamacion y dolor.
WO2014021591A3 (ko) 신규한 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
MX2011005899A (es) Composicion farmacéutica con antihistamínico no sedante y combinaciones.
MX2012000360A (es) Combinacion de un atiinflamatorio no esteroideo y un antiespasmodico.
MX2012014498A (es) Composicion farmaceutica de rosuvastatina.
WO2008132608A3 (en) Combined use of egf pathway inhibitors and differentiation promoting compounds
CL2010001230A1 (es) Metodo para inhibir la melanogenesis que comprende administrar un compuesto esteroidal; composicin farmaceutica; formulacion topica, util en el tratamiento de una enfermedad o condicion que involucra melanogenesis.

Legal Events

Date Code Title Description
FG Grant or registration